These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 7494182)

  • 1. An investigation into the effects of preparation conditions and storage on the rate of drug release from pharmaceutical glyceride bases.
    Sutananta W; Craig DQ; Newton JM
    J Pharm Pharmacol; 1995 May; 47(5):355-9. PubMed ID: 7494182
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An evaluation of the mechanisms of drug release from glyceride bases.
    Sutananta W; Craig DQ; Newton JM
    J Pharm Pharmacol; 1995 Mar; 47(3):182-7. PubMed ID: 7602477
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Study of in-vitro release characteristics of carbamazepine extended release semisolid matrix filled capsules based on Gelucires.
    Galal S; El Massik MA; Abdallah OY; Daabis NA
    Drug Dev Ind Pharm; 2004 Sep; 30(8):817-29. PubMed ID: 15521328
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of aging on the release of salbutamol sulfate from lipid matrices.
    San Vicente A; Hernández RM; Gascón AR; Calvo MB; Pedraz JL
    Int J Pharm; 2000 Nov; 208(1-2):13-21. PubMed ID: 11064207
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of formulation on the rheology of theophylline compound suspensions in Gelucires.
    Ratsimbazafy V; Bourret E; Brossard C
    J Pharm Pharmacol; 1997 Sep; 49(9):852-7. PubMed ID: 9306251
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Influence of the composition of glycerides on the solid-state behaviour and the dissolution profiles of solid lipid extrudates.
    Windbergs M; Strachan CJ; Kleinebudde P
    Int J Pharm; 2009 Nov; 381(2):184-91. PubMed ID: 19782882
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of formulation and process variables on solid-state stability of theophylline in controlled release formulations.
    Korang-Yeboah M; Rahman Z; Shah D; Mohammad A; Wu S; Siddiqui A; Khan MA
    Int J Pharm; 2016 Feb; 499(1-2):20-28. PubMed ID: 26688036
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rheological behavior of drug suspensions in Gelucire mixtures and proxyphylline release from matrix hard gelatin capsules.
    Ratsimbazafy V; Bourret E; Duclos R; Brossard C
    Eur J Pharm Biopharm; 1999 Nov; 48(3):247-52. PubMed ID: 10612036
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vitro and in vivo evaluation of potassium chloride sustained release formulation prepared with saturated polyglycolyed glycerides matrices.
    Wu PC; Tsai MJ; Huang YB; Chang JS; Tsai YH
    Int J Pharm; 2002 Aug; 243(1-2):119-24. PubMed ID: 12176300
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation and enhancement of physical stability of semi-solid dispersions containing piroxicam into hard gelatin capsules.
    Karataş A; Bekmezci S
    Acta Pol Pharm; 2013; 70(5):883-97. PubMed ID: 24147368
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development and physicochemical characterization of saquinavir mesylate solid dispersions using Gelucire 44/14 or PEG 4000 as carrier.
    Caon T; Konig RA; da Cruz AC; Cardoso SG; Campos CE; Cuffini SL; Koester LS; Simões CM
    Arch Pharm Res; 2013 Sep; 36(9):1113-25. PubMed ID: 23700292
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Wax-based sustained release matrix pellets prepared by a novel freeze pelletization technique II. In vitro drug release studies and release mechanisms.
    Cheboyina S; Wyandt CM
    Int J Pharm; 2008 Jul; 359(1-2):167-73. PubMed ID: 18495391
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Optimization of liberation of theophylline derivatives from Gelucire matrix tablets].
    Ratsimbazafy V; Brossard C
    Pharm Acta Helv; 1992; 67(5-6):166-71. PubMed ID: 1438455
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Kinetics of liberation of the theophylline in semi-solid matrix based of Gelucire].
    Ortigosa CA; Lasserre YJ
    Ann Pharm Fr; 2004 Mar; 62(2):128-32. PubMed ID: 15107730
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Extrusion-spheronization manufacture of Gelucire matrix beads.
    Montoussé C; Pruvost M; Rodriguez F; Brossard C
    Drug Dev Ind Pharm; 1999 Jan; 25(1):75-80. PubMed ID: 10028421
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Improved solubility and dissolution rate of piroxicam using gelucire 44/14 and labrasol.
    Karataş A; Yüksel N; Baykara T
    Farmaco; 2005 Sep; 60(9):777-82. PubMed ID: 16084514
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Feasibility study of semi-solid matrices of theophylline-containing polyethyleneglycols].
    Ortigosa CA; Lasserre YJ
    Ann Pharm Fr; 2004 Jan; 62(1):37-42. PubMed ID: 14747771
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Use of artificial neural networks to predict drug dissolution profiles and evaluation of network performance using similarity factor.
    Peh KK; Lim CP; Quek SS; Khoh KH
    Pharm Res; 2000 Nov; 17(11):1384-8. PubMed ID: 11205731
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Formulation and pharmacokinetics of gelucire solid dispersions of flurbiprofen.
    Daravath B; Tadikonda RR; Vemula SK
    Drug Dev Ind Pharm; 2015; 41(8):1254-62. PubMed ID: 25039470
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Graft copolymers of ethyl methacrylate on waxy maize starch derivatives as novel excipients for matrix tablets: drug release and fronts movement kinetics.
    Marinich JA; Ferrero C; Jiménez-Castellanos MR
    Eur J Pharm Biopharm; 2012 Apr; 80(3):674-81. PubMed ID: 22210473
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.